Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Utility of TRPS1 in Malignant Effusion Cytology.
Tjendra Y, Millan N, Velez Torres JM, Zuo Y, Garcia-Buitrago M, Jorda M, Gomez-Fernandez CR. Tjendra Y, et al. Among authors: zuo y. Acta Cytol. 2023;67(3):273-279. doi: 10.1159/000528249. Epub 2023 Jan 12. Acta Cytol. 2023. PMID: 36634642
Don't SUMP it! Utility of PLAG1 immunocytochemistry in basaloid SUMP subcategory.
Sanchez-Avila M, Tjendra Y, Zuo Y, Ruiz-Cordero R, Garcia-Buitrago M, Jorda M, Gomez-Fernandez C, Velez Torres JM. Sanchez-Avila M, et al. Among authors: zuo y. Cancer Cytopathol. 2024 Jan;132(1):60-68. doi: 10.1002/cncy.22762. Epub 2023 Sep 13. Cancer Cytopathol. 2024. PMID: 37702124 Free article.
Exploring the atypia of undetermined significance: Malignant ratio, ThyroSeq v3 positive call rate, molecular-derived risk of malignancy, and risk of malignancy as possible quality metric tools in thyroid cytology.
Velez Torres JM, Curnow PM, Tjendra Y, Jorda M, Fernandez CG, Buitrago MG, Zuo Y, Cordero RR. Velez Torres JM, et al. Among authors: zuo y. Cancer Cytopathol. 2024 Aug;132(8):491-498. doi: 10.1002/cncy.22820. Epub 2024 Apr 9. Cancer Cytopathol. 2024. PMID: 38594180
Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performance.
Mejia-Mejia O, Bravo-Gonzalez A, Sanchez-Avila M, Tjendra Y, Santoscoy R, Drews-Elger K, Zuo Y, Arias-Abad C, Gomez C, Garcia-Buitrago M, Nadji M, Jorda M, Velez-Torres JM, Ruiz-Cordero R. Mejia-Mejia O, et al. Among authors: zuo y. Cancer Cytopathol. 2024 Aug;132(8):481-490. doi: 10.1002/cncy.22821. Epub 2024 Apr 9. Cancer Cytopathol. 2024. PMID: 38594192
3,383 results